Icore Global Medicines Limited - Company Profile

It is a chemicals public limited company based in Kolkata, West Bengal, India, established in 2009.
2009 Kolkata, West Bengal, India Active
Last Updated:
Access Report
About Icore Global Medicines Limited

Icore Global Medicines Limited, a active public limited company, was established on 02 June 2009 in Kolkata, West Bengal, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24232WB2009PLC135575. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.50 M.

It upholds a active non-compliant status. Its leadership includes Swarup Mitra (Additional Director), Swapan Roy (Director), Kanika Maiti (Director). Its latest AGM occurred on 25 September 2013, with the balance sheet filed on 31 March 2013. It is based at 54/2, Rafi Ahmed Kidwai Road, Kolkata, West Bengal, 700016.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232WB2009PLC135575

  • Registration Number

    135575

  • Incorporation Date

    02 June 2009

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Kolkata

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 16 Year, 8 Months
  • Last Filing with ROC 31 Mar 2013
Company report

Icore Global Medicines Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Icore Global Medicines Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Icore Global Medicines Limited?
Current Directors
Name Designation Appointment Date Status
Swarup Mitra Additional Director 02 Feb 2010 Current
Swapan Roy Director 02 Jun 2009 Current
Kanika Maiti Director 02 Jun 2009 Current
Anukul Maiti Director 02 Jun 2009 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Icore Global Medicines.

Enhance accessibility to Icore Global Medicines's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Icore Global Medicines revenue growth over time
Icore Global Medicines profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Icore Global Medicines?

Unlock access to Icore Global Medicines's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Icore Global Medicines?

Unlock and access historical data on people associated with Icore Global Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Icore Global Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Icore Global Medicines's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Icore Global Medicines
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Icore Global Medicines Limited last Annual general meeting of members was held on 25 Sep 2013 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Icore Global Medicines Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Kolkata. was completed.

  • Director Appointment

    The activity Swarup Mitra was appointed as a Additional Director was appointed as a Additional Director on 02 Feb 2010 & has been associated with this company since 16 years 17 days . was completed.

  • Director Appointment

    The activity Swapan Roy was appointed as a Director was appointed as a Director on 02 Jun 2009 & has been associated with this company since 16 years 8 months . was completed.

  • Director Appointment

    Kanika Maiti was appointed as a Director was appointed as a Director on 02 Jun 2009 & has been associated with this company since 16 years 8 months . was recorded as a recent event.

  • Director Appointment

    The activity Anukul Maiti was appointed as a Director was appointed as a Director on 02 Jun 2009 & has been associated with this company since 16 years 8 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Icore Global Medicines Limited?

The CIN of Icore Global Medicines Limited is U24232WB2009PLC135575.

Where is Icore Global Medicines Limited headquartered?

Icore Global Medicines Limited is headquartered at 54/2, Rafi Ahmed Kidwai Road, Kolkata, West Bengal, 700016.

When was Icore Global Medicines Limited incorporated?

Icore Global Medicines Limited was incorporated on 02 June 2009.

Who are the current directors of Icore Global Medicines Limited?

The current directors of Icore Global Medicines Limited are

What is the primary industry of Icore Global Medicines Limited?

The primary industry of Icore Global Medicines Limited is Chemicals.

Is Icore Global Medicines Limited a listed company?

Icore Global Medicines Limited is unlisted.

What is the capital structure of Icore Global Medicines Limited?

The authorized capital of Icore Global Medicines Limited is ₹5.00 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Icore Global Medicines Limited?

The compliance status of Icore Global Medicines Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available